Children's Hospital Capital Institute of Pediatrics (CIP)

Beijing

0 studies enrolling now · 1 studies all time

What they study most

Fibrodysplasia Ossificans Progressiva

Studies at this site

• A Study to Assess the Effectiveness and Safety of 2 Dosage Regimens of Oral Fidrisertib (IPN60130) for the Treatment of Fibrodysplasia Ossificans Progressiva (FOP). — Stopped early